| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1165-1170, Copyright © 1994 by Endocrine Society
ARTICLES |
DR Mason, KK Arora, LM Mertz and KJ Catt
Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
GnRH is known to down-regulate its pituitary receptors by mechanisms that include endocytosis of the agonist-receptor complex. To evaluate the extent to which changes in receptor synthesis contribute to this process, the effects of GnRH and its analogs on GnRH receptor number and messenger RNA (mRNA) levels were analyzed in the alpha T3-1 gonadotroph cell line. Treatment with GnRH or its potent agonist analog, des-Gly10-[D-Ala6]GnRH N-ethylamide, reduced GnRH receptor number in a time- and dose-dependent manner, with a half-maximal decrease in response to 10(-6) M GnRH or agonist analog by 75 min. The maximum decrease in receptor number (to 31% of the control value) was sustained for up to 72 h. In alpha T3-1 cells incubated with 10(-8) M GnRH or agonist analog, the GnRH receptors fell by 28% and 46% after 2 h, respectively; no change in receptors occurred after treatment with 10(-8) M GnRH antagonist ([D-pGlu1,D-Phe2,D-Trp3,6]GnRH). Time- and dose-dependent reductions in the level of receptor mRNA were also observed after treatment of alpha T3-1 cells with GnRH and the agonist analog. However, the maximal reduction in mRNA levels (to 60-70% of the control value) was consistently less than the decline in receptor number. These results indicate that the mechanism of GnRH receptor down- regulation in alpha T3-1 gonadotrophs includes reduction of receptor synthesis secondary to decreases in receptor mRNA levels. The finding that reductions in mRNA levels were relatively less than the decreases in receptor number is consistent with the involvement of additional mechanisms, including endocytosis and degradation, in down-regulation of the GnRH receptor.
This article has been cited by other articles:
![]() |
T. Cogliati, P. Delgado-Romero, E. R. Norwitz, J. Guduric-Fuchs, U. B. Kaiser, S. Wray, and I. R. Kirsch Pubertal Impairment in Nhlh2 Null Mice Is Associated with Hypothalamic and Pituitary Deficiencies Mol. Endocrinol., December 1, 2007; 21(12): 3013 - 3027. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Zhang and M S Roberson Role of MAP kinase phosphatases in GnRH-dependent activation of MAP kinases J. Mol. Endocrinol., February 1, 2006; 36(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, D. A. Austin, and N. J. G. Webster Gonadotropin-Releasing Hormone-Desensitized L{beta}T2 Gonadotrope Cells Are Refractory to Acute Protein Kinase C, Cyclic AMP, and Calcium-Dependent Signaling Endocrinology, October 1, 2003; 144(10): 4354 - 4365. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Junoy, H. Maccario, J.-L. Mas, A. Enjalbert, and S. V. Drouva Proteasome Implication in Phorbol Ester- and GnRH-Induced Selective Down-Regulation of PKC ({alpha}, {epsilon}, {zeta}) in {alpha}T3-1 and L{beta}T2 Gonadotrope Cell Lines Endocrinology, April 1, 2002; 143(4): 1386 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wells, J. C. S. Souto, J. Solava, J. Kassis, K. J. Bailey, and T. Turner Luteinizing Hormone-releasing Hormone Agonist Limits DU-145 Prostate Cancer Growth by Attenuating Epidermal Growth Factor Receptor Signaling Clin. Cancer Res., April 1, 2002; 8(4): 1251 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Halmos and A. V. Schally Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix PNAS, January 22, 2002; 99(2): 961 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kovacs and A. V. Schally Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats PNAS, October 9, 2001; 98(21): 12197 - 12202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kovacs, A. V. Schally, B. Csernus, and Z. Rekasi Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH PNAS, January 24, 2001; (2001) 31582398. [Abstract] [Full Text] |
||||
![]() |
S. Wolfahrt, B. Kleine, H. Jarry, and W. G. Rossmanith Endogenous regulation of the GnRH receptor by GnRH in the human placenta Mol. Hum. Reprod., January 1, 2001; 7(1): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Cheng, E. S. W. Ngan, S. K. Kang, B. K. C. Chow, and P. C. K. Leung Transcriptional Down-Regulation of Human Gonadotropin-Releasing Hormone (GnRH) Receptor Gene by GnRH: Role of Protein Kinase C and Activating Protein 1 Endocrinology, October 1, 2000; 141(10): 3611 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Cheng, P. S. Nathwani, and P. C. K. Leung Regulation of Human Gonadotropin-Releasing Hormone Receptor Gene Expression in Placental Cells Endocrinology, July 1, 2000; 141(7): 2340 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Nathwani, S. K. Kang, K. W. Cheng, K.-C. Choi, and P. C. K. Leung Regulation of Gonadotropin-Releasing Hormone and Its Receptor Gene Expression by 17{beta}-Estradiol in Cultured Human Granulosa-Luteal Cells Endocrinology, May 1, 2000; 141(5): 1754 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baratti-Elbaz, N. Ghinea, O. Lahuna, H. Loosfelt, C. Pichon, and E. Milgrom Internalization and Recycling Pathways of the Thyrotropin Receptor Mol. Endocrinol., October 1, 1999; 13(10): 1751 - 1765. [Abstract] [Full Text] |
||||
![]() |
G. Maya-Núñez and P. M. Conn Transcriptional Regulation of the Gonadotropin-Releasing Hormone Receptor Gene Is Mediated in Part by a Putative Repressor Element and by the Cyclic Adenosine 3',5'-Monophosphate Response Element Endocrinology, August 1, 1999; 140(8): 3452 - 3458. [Abstract] [Full Text] |
||||
![]() |
K. K. Arora, H.-O. Chung, and K. J. Catt Influence of a Species-Specific Extracellular Amino Acid on Expression and Function of the Human Gonadotropin-Releasing Hormone Receptor Mol. Endocrinol., June 1, 1999; 13(6): 890 - 896. [Abstract] [Full Text] |
||||
![]() |
H.-F. Chen, E.-B. Jeung, M. Stephenson, and P. C. K. Leung Human Peripheral Blood Mononuclear Cells Express Gonadotropin-Releasing Hormone (GnRH), GnRH Receptor, and Interleukin-2 Receptor {gamma}-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 743 - 750. [Abstract] [Full Text] |
||||
![]() |
E. R. Norwitz, G. R. Cardona, K.-H. Jeong, and W. W. Chin Identification and Characterization of the Gonadotropin-releasing Hormone Response Elements in the Mouse Gonadotropin-releasing Hormone Receptor Gene J. Biol. Chem., January 8, 1999; 274(2): 867 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vrecl, L. Anderson, A. Hanyaloglu, A. M. McGregor, A. D. Groarke, G. Milligan, P. L. Taylor, and K. A. Eidne Agonist-Induced Endocytosis and Recycling of the Gonadotropin-Releasing Hormone Receptor: Effect of {beta}-Arrestin on Internalization Kinetics Mol. Endocrinol., December 1, 1998; 12(12): 1818 - 1829. [Abstract] [Full Text] |
||||
![]() |
X. Lin and P. M. Conn Transcriptional Activation of Gonadotropin-Releasing Hormone (GnRH) Receptor Gene by GnRH and Cyclic Adenosine Monophosphate Endocrinology, September 1, 1998; 139(9): 3896 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kamegai, T. G. Unterman, L. A. Frohman, and R. D. Kineman Hypothalamic/Pituitary-Axis of the Spontaneous Dwarf Rat: Autofeedback Regulation of Growth Hormone (GH) Includes Suppression of GH Releasing-Hormone Receptor Messenger Ribonucleic Acid Endocrinology, August 1, 1998; 139(8): 3554 - 3560. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Arora, Z. Cheng, and K. J. Catt Mutations of the Conserved DRS Motif in the Second Intracellular Loop of the Gonadotropin-Releasing Hormone Receptor Affect Expression, Activation, and Internalization Mol. Endocrinol., August 1, 1997; 11(9): 1203 - 1212. [Abstract] [Full Text] |
||||
![]() |
G. Aleppo, S. F. Moskal II, P. A. De Grandis, R. D. Kineman, and L. A. Frohman Homologous Down-Regulation of Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Levels Endocrinology, March 1, 1997; 138(3): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. B. Kaiser, P. M. Conn, and W. W. Chin Studies of Gonadotropin-Releasing Hormone (GnRH) Action Using GnRH Receptor-Expressing Pituitary Cell Lines Endocr. Rev., February 1, 1997; 18(1): 46 - 70. [Abstract] [Full Text] |
||||
![]() |
M. Kovacs, A. V. Schally, B. Csernus, and Z. Rekasi Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH PNAS, February 13, 2001; 98(4): 1829 - 1834. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |